<DOC>
	<DOC>NCT01101074</DOC>
	<brief_summary>This observational study will evaluate the safety and effectiveness following administration of adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine through both an ad hoc active monitoring system and a passive surveillance of hospitalization in a large cohort.</brief_summary>
	<brief_title>Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects resident in EmiliaRomagna and either registered with the AUSL of Reggio Emilia, Bologna, Modena and Parma or working in the province of Reggio Emilia, Bologna, Modena and Parma included in the target groups described in the Study Protocol vaccination with H1N1sw vaccine Focetria is recommended according to the national pandemic plan adopted at the local level will be eligible for enrolment. Subjects already vaccinated with another pandemic vaccine or with known contraindications to Focetria, will be excluded from this study. Patients institutionalized in Hospital, Nursing Homes, Rehabilitation Centers, as well as homecared patients, will also be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Swine Flu A (H1N1) vaccine</keyword>
	<keyword>Adjuvanted flu egg derived</keyword>
	<keyword>Novel influenza A (H1N1): a new flu virus of swine origin</keyword>
</DOC>